CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced that the Japan Patent Office ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a pioneer of artificial intelligence-driven precision cardiovascular medicine tests, today announced its AI-driven molecular ...

Jun 10, 2025, 8:35 AM ETCardio Diagnostics Holdings, Inc. (CDIO) “We are proud to support this important innovation from the University of Iowa ecosystem,” said Marie Kerbeshian, Ph.D., Executive ...

Cardiovascular disease is the leading cause of death worldwide. The primary objective of therapies is to reduce the incidence of major adverse cardiovascular events (MACE). The leading class of drugs ...

Cardiovascular disease(CVD) is currently the leading cause of death globally. The World Health Organisation (WHO) reported that CVD, which encompasses all conditions linked to the heart and blood ...

MedAxiom and AccuCode AI today announced the launch of AccuCode CV, an artificial intelligence (AI)-augmented cardiovascular ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. One person dies of cardiovascular disease (CVD) every 34 ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often fail to make it to patients because all critical stakeholders are not ...